Incidence of Demodex Folliculorum in Patients with End Stage Chronic Renal Failure

Abstract

Our findings indicate that the DF number is increased in ESRF patients on dialysis treatment. We recommend that demodicidosis should be included in the differential diagnosis of facial eruptions in patients with ESRF.

Comparison of Demodex folliculorum density in haemodialysis patients with a control group

“…In our study DF density was 5.11 ± 5.65/cm 2 in patients and 2.55 ± 1.6/cm 2 in controls. DF density in our controls was higher than in Karincaoglu's study 19 …”

Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link

“… 76 have observed a higher incidence of high Dd (≥5 D/cm 2 ) in patients receiving chemotherapy than in a control group, and Karincaoglu et al. 77 have observed that the Dd is higher in patients with end stage chronic renal failure (6.12 D/cm 2 , n = 62) than in the control patients (0.31 D/cm 2 , n = 62) ( P = 0,000). Other factors like erythematotelangiectatic rosacea, skin temperature, 56 lack of soap, 12,15,64,70 or thick layers of make‐up, 15,70 and sebaceous hyperplasia could also favour D proliferation.…”

<i>Demodex </i>Mites – Commensals, Parasites or Mutualistic Organisms?

“…Rosaceiform dermatitis has been reported following repeated facial application of topical steroids and other immunomodulators with similarly increased numbers of mites recorded [13] . Several other studies have shown that Demodex mite numbers are increased in immunosuppressed patients, children with leukaemia receiving chemotherapy [14] , patients with HIV infection and AIDS [15,16] , patients undergoing phototherapy [17] and patients on chronic dialysis [18] .…”